WAT
WATERS CORP /DE/
NYSE · Healthcare · Medical - Diagnostics & Research · US
$421.63
−1.88%Next report
Analyst consensus
- Next report date
- Nov 3, 2026
- EPS estimate
- $4.01
- Revenue estimate
- $1.8B
Latest reported
- Last report date
- Aug 4, 2026
- EPS actual
- $3.05
- EPS estimate
- $3.01
- Revenue actual
- $1.6B
- Revenue estimate
- $1.6B
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 12
- EPS misses (12Q)
- 0
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +7.3%
- Revenue beats (12Q)
- 9
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $448
- PT range
- $390 – $490
- Analysts
- 11
9 Buy2 Hold0 Sell
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 4, 2026 | $3.01 | $3.05 | Beat 1.33% | $1.6B |
| May 5, 2026 | $2.31 | $2.70 | Beat 16.88% | $1.3B |
| Feb 12, 2025 | $4.03 | $4.10 | Beat 1.74% | $872.7M |
| Nov 1, 2024 | $2.68 | $2.93 | Beat 9.33% | $740.3M |
| Jul 31, 2024 | $2.56 | $2.63 | Beat 2.73% | $708.5M |
| Aug 2, 2023 | $2.59 | $2.80 | Beat 8.11% | $740.6M |
| Feb 15, 2023 | $3.73 | $3.84 | Beat 2.87% | $858.5M |
| Nov 1, 2022 | $2.57 | $2.64 | Beat 2.72% | $708.6M |
| Aug 2, 2022 | $2.66 | $2.75 | Beat 3.38% | $714.3M |
| May 3, 2022 | $2.32 | $2.80 | Beat 20.69% | $690.6M |
| Feb 1, 2022 | $3.47 | $3.67 | Beat 5.76% | $836.4M |
| Nov 2, 2021 | $2.35 | $2.66 | Beat 13.19% | $659.2M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 3, 2026